Literature DB >> 17387697

Poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as polymeric emulsifier for the preparation of biodegradable nanoparticles.

Geneviève Gaucher1, Monika Poreba, François Ravenelle, Jean-Christophe Leroux.   

Abstract

Poly(D,L-lactide) (PDLLA) amphiphilic block copolymers were employed as emulsifiers in the preparation of PDLLA nanoparticles by an oil/water emulsion solvent evaporation technique. The surface-active properties of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) (PVP-b-PDLLA) toward the biphasic system were compared to those of polyethylene glycol(PEG)-b-PDLLA of similar composition. PVP-b-PDLLA was found to be a suitable emulsifier for dichloromethane/water emulsions, yielding narrowly distributed nanoparticles (<250 nm) surrounded by a hydrophilic PVP corona. PEG-b-PDLLA, however, was only effective in producing appropriately sized nanoparticles when dichloromethane was replaced with ethyl acetate. Furthermore, the lyoprotectant properties of PVP allowed the freeze-dried nanoparticles to recover their initial size following reconstitution, while PEG-coated nanoparticles could not be redispersed following lyophilization. Two poorly water-soluble drugs, that is, paclitaxel and etoposide, were efficiently loaded into PVP-decorated PDLLA nanoparticles. The entrapment efficiency of etoposide was significantly enhanced by adding MgCl2 to the aqueous phase. It was found that the nanoparticles released the drugs progressively over several days in vitro. The obtained experimental results were corroborated with the theoretical compatibility between a given drug, polymer, and solvent, predicted by total solubility parameters. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387697     DOI: 10.1002/jps.20833

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  A novel size-tunable nanocarrier system for targeted anticancer drug delivery.

Authors:  Yuanpei Li; Kai Xiao; Juntao Luo; Joyce Lee; Shirong Pan; Kit S Lam
Journal:  J Control Release       Date:  2010-03-06       Impact factor: 9.776

2.  Paclitaxel Nano-Delivery Systems: A Comprehensive Review.

Authors:  Ping Ma; Russell J Mumper
Journal:  J Nanomed Nanotechnol       Date:  2013-02-18

Review 3.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118

4.  Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant.

Authors:  Ming-Hsi Huang; Chiung-Yi Huang; Shu-Pei Lien; Syuan-Yi Siao; Ai-Hsiang Chou; Hsin-Wei Chen; Shih-Jen Liu; Chih-Hsiang Leng; Pele Chong
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

5.  Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer.

Authors:  Pallabita Chowdhury; Prashanth K B Nagesh; Sheema Khan; Bilal B Hafeez; Subhash C Chauhan; Meena Jaggi; Murali M Yallapu
Journal:  Acta Pharm Sin B       Date:  2017-12-10       Impact factor: 11.413

6.  A novel nanoparticle loaded with methyl caffeate and caffeic acid phenethyl ester against Ralstonia solanacearum-a plant pathogenic bacteria.

Authors:  Jin-Zheng Wang; Cheng-Hai Yan; Xiao-Rui Zhang; Qing-Bo Tu; Yan Xu; Sheng Sheng; Fu-An Wu; Jun Wang
Journal:  RSC Adv       Date:  2020-01-23       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.